Reuters

US Supreme Court backs generic drugmaker in 'skinny label' patent case

Supreme Court Rules in Favor of Generic Manufacturer in 'Skinny Label' Patent Dispute

The US Supreme Court has issued a ruling supporting a generic pharmaceutical company in a legal battle concerning the use of "skinny labels" in patent litigation.


Source: Reuters Generated at: 2026-06-04 15:38:05 UTC

Related Articles

New York Times

Senators Cassidy and Booker Ask Judge to Maintain Block on $1.8 Billion Fund

Senators Cassidy and Booker urged a judge to uphold the block on a $1.8 billion fund, warning it threatens the constitut...

Reuters

Qantas weighs order for 20 Boeing or Airbus wide-body jets, sources say

Qantas is evaluating an order for 20 wide-body jets from either Boeing or Airbus, according to sources.

Jan. 6 Rioter Is Hired to Work in Sensitive Pentagon Office
New York Times

Jan. 6 Rioter Is Hired to Work in Sensitive Pentagon Office

Elias Irizarry, a Jan. 6 rioter, was hired by the Pentagon for a sensitive office role despite being pictured with a pol...

University of Texas to Remove Cesar Chavez Statue From Austin Campus
New York Times

University of Texas to Remove Cesar Chavez Statue From Austin Campus

The University of Texas at Austin will remove a statue of Cesar Chavez from its campus. This decision follows a review o...

Reuters

How flesh-eating screwworms in cattle could raise US beef prices

Flesh-eating screwworms in US cattle threaten to raise beef prices. This infestation poses a significant risk to livesto...

Supreme Court Finds S.E.C. Can Strip Wrongdoers of Illegal Financial Gains, Even Without Proof of Victim Loss
New York Times

Supreme Court Finds S.E.C. Can Strip Wrongdoers of Illegal Financial Gains, Even Without Proof of Victim Loss

The Supreme Court unanimously ruled that the SEC can strip wrongdoers of illegal profits without proving victim losses, ...